Special Drug Use Investigation of Xarelto for Venous thromboembolism (VTE) (JPMS-XAR-VTE)
The objective of this investigation is to assess safety
and effectiveness of Xarelto under practice routine use
in VTE secondary prevention after acute DVT, focusing
on hemorrhagic-related AEs, recurrent venous
thromboembolism (PE/DVT), all-cause mortality.
This study is a company sponsored, one- arm
prospective cohort study with patients to whom
Rivaroxaban treatment for VTE (PE/DVT) has been
The study includes a standard observation period (1
year) and an extension survey period (2 years, at the
- Patients who start rivaroxaban for VTE(pulmonary embolism, deep vein thrombosis) anticoagulation therapy.
- Patients who are contraindicated based on the product label and have already received Xarelto treatment.
Many locations, Japan
E-mail: [email protected]
Phone: (+) 1-888-8422937
Special Drug Use Investigation of Xarelto for VTE